Tumor Nucleic Acid Detection Using Circularized Concatemers

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting tumor nucleic acids in cell-free biological samples face challenges in achieving low limit of detection (LOD) and high sensitivity, particularly in tumor-informed approaches, due to logistical complexities and high error rates in sequencing, which are costly and time-consuming.

Innovation Solution

The method involves circularizing nucleic acids from the sample to create concatemers, followed by amplification and sequencing at a controlled depth, combined with selection techniques to remove non-target sequences, utilizing polymerases with strand-displacement activity, and employing concatemer sequencing for error correction.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional sequencing methods are used for tumor nucleic acid detection, then sequencing depth can be increased to improve detection sensitivity, but cost and turnaround time increase significantly

Engineering Contradiction:
Improvedetection sensitivityVSAvoidturnaround time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent applies preliminary action by performing circularization of nucleic acids before sequencing. This pre-processing step creates concatemers that can be sequenced at lower depth while maintaining detection sensitivity, thereby reducing turnaround time and cost without sacrificing measurement precision.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent changes the parameter of nucleic acid structure from linear to circular form through circularization. This structural parameter change enables the use of lower sequencing depth (reading 1-5x coverage instead of conventional higher depth) while maintaining or improving detection sensitivity through concatemer-based error correction.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If conventional sequencing methods are used for tumor nucleic acid detection, then sequencing depth can be increased to improve detection sensitivity, but cost increases significantly

Engineering Contradiction:
Improvedetection sensitivityVSAvoidcost
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The patent applies preliminary action by performing circularization of nucleic acids before sequencing. This pre-processing step creates concatemers that can be sequenced at lower depth while maintaining detection sensitivity, thereby reducing turnaround time and cost without sacrificing measurement precision.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent changes the parameter of nucleic acid structure from linear to circular form through circularization. This structural parameter change enables the use of lower sequencing depth (reading 1-5x coverage instead of conventional higher depth) while maintaining or improving detection sensitivity through concatemer-based error correction.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If high sequencing depth is used to detect tumor-specific variants, then detection accuracy improves, but error rates in sequencing increase

Engineering Contradiction:
Improvedetection accuracyVSAvoiderror rate
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent applies preliminary action by performing circularization of nucleic acids before sequencing. This pre-processing step creates concatemers that can be sequenced at lower depth while maintaining detection sensitivity, thereby reducing turnaround time and cost without sacrificing measurement precision.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses copying through concatemer formation, where multiple copies of the circularized nucleic acid are generated and sequenced. This copying approach allows error correction by comparing multiple reads of the same sequence, improving reliability without requiring extremely high sequencing depth.

Inventive Principle:
Principle #26Copying

4Productivity

If shallow sequencing is used to reduce cost and time, then detection sensitivity decreases, but the method becomes cost-effective and fast

Engineering Contradiction:
Improvedetection speedVSAvoiddetection sensitivity
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The patent changes the parameter of nucleic acid structure from linear to circular form through circularization. This structural parameter change enables the use of lower sequencing depth (reading 1-5x coverage instead of conventional higher depth) while maintaining or improving detection sensitivity through concatemer-based error correction.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses copying through concatemer formation, where multiple copies of the circularized nucleic acid are generated and sequenced. This copying approach allows error correction by comparing multiple reads of the same sequence, improving reliability without requiring extremely high sequencing depth.

Inventive Principle:
Principle #26Copying

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables efficient and cost-effective genome-wide error suppression, allowing for sensitive and fast detection of tumor-specific sequence variants, even at low tumor burden, with improved LOD and reduced turnaround time.

Implementation Method 1

amplifying the circularized nucleic acid is effected by a polymerase having strand-displacement activity

Methodology Applied
Scientific EffectStrand-displacement activity:

Implementation Method 2

amplifying the circularized nucleic acid is effected by a polymerase having 5′ to 3′ exonuclease activity

Methodology Applied
Scientific Effect5' to 3' exonuclease activity:

Implementation Method 3

circularizing comprises ligating ends of the nucleic acid or a derivative thereof to one another

Methodology Applied
Scientific EffectLigation:

Data Source

PatentUS20250327135A1Tumor nucleic acid identification methods
Publication Date: 2025.10.23 ACCUSCAN SCIENCES INC
  • US20250327135A1 patent drawing
  • US20250327135A1 patent drawing
  • US20250327135A1 patent drawing

AI summary

Provided herein are methods of detecting tumor nucleic acids in a biological sample of a subject.